DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the PE ratio of Deccan Health Care Ltd?

Deccan Health Care Ltd has a price-to-earnings (PE) ratio of 13.2 in the Healthcare Services sector.

What is the market capitalisation of Deccan Health Care Ltd?

Deccan Health Care Ltd has a market capitalisation of approximately ₹33 crore.

Deccan Health Care Ltd

DECCANHEALTHCARELTD·NSE·Healthcare Services

₹0.00▲ +0.00 (+0.00%)

⚠️Trading suspended. Not a live price.

Healthcare Services · Healthcare Service Provider

A steady, established business

52W₹7

₹23-41%

Open

—

High

—

Low

—

Prev Close

—

Volume

—

VWAP

—

Snapshot

Key fundamentals

Market Cap

₹33 Cr

P/E Ratio

13.20Cheap

P/B Ratio

0.30

EPS

₹1.01

Book Value

₹44.60

ROE

2.30%Weak

ROCE

3.28%Weak

Dividend Yield

0.00%

Debt / Equity

0.04Low

Face Value

₹10.00

52W High

₹22.99

52W Low

₹6.65

Sector

Healthcare Services

Industry

Healthcare Service Provider

Expensive

None moatMedium uncertainty

Fair value estimate

₹37

No recent traded price

BearFair valueBull

₹32₹37₹43

/100

Business quality — Watch the fundamentals

Growth 50Profitability 3Efficiency 0Valuation 95

Plain English

Our view

A steady, established business
Virtually debt-free balance sheet
Weak returns on equity (2%)

Strengths

Virtually debt-free balance sheet
Reasonably priced at 13× earnings

Risks

Weak returns on equity (2%)

How we got there

Fair value methods

Residual income

2% ROE fading to 12% over ~3 yrs, on ₹45 book

₹39

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹32

Analyst target

No analyst coverage

—

Blended fair value₹37

What the numbers say

Investment thesis

Bull case

Virtually debt-free balance sheet
Reasonably priced at 13× earnings

Bear case

Weak returns on equity (2%)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

13.2Cheap

Below 15× is value territory; above 35× prices in strong growth

ROE

2.3%Weak

Above 15% is considered healthy for Indian equities

ROCE

3.3%Weak

Above 18% means capital is working hard

Debt/Eq

0.04Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹33 Cr

P/B

0.30

EPS

₹1.01

Div Yield

—

What changed

Recent changes

Domestic institutions+0.3% stake last quarter
Promoters+1.04% stake last quarter

What matters

News impact

Overview

Valuation

Attractive

P/E 13.2×

Growth

Strong

+22% rev CAGR

Profitability

Modest

2.3% ROE

Financial health

Rock solid

D/E 0.04

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover—

Trades—

VWAP—

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+22.1%

+19.4%

10Y

—

Profit

+100.3%

+44.9%

10Y

—

EPS

+77.7%

+32.2%

10Y

—

Profile

Pros

Company is almost debt free.
Stock is trading at 0.30 times its book value

Watch-outs

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Promoter holding is low: 19.5%
Company has a low return on equity of 1.72% over last 3 years.
Contingent liabilities of Rs.16.8 Cr.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Promoters raised their stake by 1.04 pts; domestic institutions added 0.31 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

19%

Promoter

Promoters

19.5%+1.04

Public

54.0%+7.61

FII / FPI

0.0%0.00

DII

5.7%+0.31

Others

20.9%

Total shareholders

4,004+78 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter19.46%

DII5.68%

Public53.97%

Others20.89%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 1996, Deccan Healthcare Ltd is a manufacturer of Fast moving consumer health products[1]